Minority Views
[To accompany H.R. 2483]
The Committee on Energy and Commerce, to whom was referred
the bill (H.R. 2483) to reauthorize certain programs that
provide for opioid use disorder prevention, treatment, and
recovery, and for other purposes, having considered the same,
reports favorably thereon with an amendment and recommends that
the bill as amended do pass.
CONTENTS
Page
Purpose and Summary.............................................. 14
Background and Need for Legislation.............................. 15
Committee Action................................................. 16
Committee Votes.................................................. 16
Oversight Findings and Recommendations........................... 18
New Budget Authority, Entitlement Authority, and Tax Expenditures 18
Congressional Budget Office Estimate............................. 18
Federal Mandates Statement....................................... 18
Statement of General Performance Goals and Objectives............ 18
Duplication of Federal Programs.................................. 18
Related Committee and Subcommittee Hearings...................... 18
Committee Cost Estimate.......................................... 19
Earmark, Limited Tax Benefits, and Limited Tariff Benefits....... 19
Advisory Committee Statement..................................... 19
Applicability to Legislative Branch.............................. 19
Section-by-Section Analysis of the Legislation................... 19
Changes in Existing Law Made by the Bill, as Reported............ 24
Minority, Additional, or Dissenting Views........................ 120
Exchange of Letters with Additional Committees of Referral....... 122
The amendment is as follows:
Strike all after the enacting clause and insert the
following:
SECTION 1. SHORT TITLE; TABLE OF CONTENTS.
(a) Short Title.--This Act may be cited as the ``SUPPORT for Patients
and Communities Reauthorization Act of 2025''.
(b) Table of Contents.--The table of contents for this Act is as
follows:
Sec. 1. Short title; table of contents.
TITLE I--PREVENTION
Sec. 101. Prenatal and postnatal health.
Sec. 102. Monitoring and education regarding infections associated with
illicit drug use and other risk factors.
Sec. 103. Preventing overdoses of controlled substances.
Sec. 104. Support for individuals and families impacted by fetal
alcohol spectrum disorder.
Sec. 105. Promoting state choice in PDMP systems.
Sec. 106. First responder training program.
Sec. 107. Donald J. Cohen National Child Traumatic Stress Initiative.
Sec. 108. Protecting suicide prevention lifeline from cybersecurity
incidents.
Sec. 109. Monitoring and reporting of child, youth, and adult trauma.
Sec. 110. Bruce's law.
Sec. 111. Guidance on at-home drug disposal systems.
Sec. 112. Assessment of opioid drugs and actions.
Sec. 113. Grant program for State and Tribal response to opioid use
disorders.
TITLE II--TREATMENT
Sec. 201. Residential treatment program for pregnant and postpartum
women.
Sec. 202. Improving access to addiction medicine providers.
Sec. 203. Mental and behavioral health education and training grants.
Sec. 204. Loan repayment program for substance use disorder treatment
workforce.
Sec. 205. Development and dissemination of model training programs for
substance use disorder patient records.
Sec. 206. Task force on best practices for trauma-informed
identification, referral, and support.
Sec. 207. Grants to enhance access to substance use disorder treatment.
Sec. 208. State guidance related to individuals with serious mental
illness and children with serious emotional disturbance.
Sec. 209. Reviewing the scheduling of approved products containing a
combination of buprenorphine and naloxone.
TITLE III--RECOVERY
Sec. 301. Building communities of recovery.
Sec. 302. Peer support technical assistance center.
Sec. 303. Comprehensive opioid recovery centers.
Sec. 304. Youth prevention and recovery.
Sec. 305. CAREER Act.
Sec. 306. Addressing economic and workforce impacts of the opioid
crisis.
TITLE IV--MISCELLANEOUS MATTERS
Sec. 401. Delivery of a controlled substance by a pharmacy to a
prescribing practitioner.
Sec. 402. Required training for prescribers of controlled substances.
TITLE I--PREVENTION
SEC. 101. PRENATAL AND POSTNATAL HEALTH.
Section 317L(d) of the Public Health Service Act (42 U.S.C. 247b-
13(d)) is amended by striking ``such sums as may be necessary for each
of the fiscal years 2019 through 2023'' and inserting ``$4,250,000 for
each of fiscal years 2026 through 2030''.
SEC. 102. MONITORING AND EDUCATION REGARDING INFECTIONS ASSOCIATED WITH
ILLICIT DRUG USE AND OTHER RISK FACTORS.
Section 317N(d) of the Public Health Service Act (42 U.S.C. 247b-
15(d)) is amended by striking ``fiscal years 2019 through 2023'' and
inserting ``fiscal years 2026 through 2030''.
SEC. 103. PREVENTING OVERDOSES OF CONTROLLED SUBSTANCES.
(a) In General.--Section 392A of the Public Health Service Act (42
U.S.C. 280b-1) is amended--
(1) in subsection (a)(2)--
(A) in subparagraph (C), by inserting ``and
associated risks'' before the period at the end; and
(B) in subparagraph (D), by striking ``opioids'' and
inserting ``substances causing overdose''; and
(2) in subsection (b)(2)--
(A) in subparagraph (B), by inserting ``, and
associated risk factors,'' after ``such overdoses'';
(B) in subparagraph (C), by striking ``coding'' and
inserting ``monitoring and identifying'';
(C) in subparagraph (E)--
(i) by inserting a comma after ``public
health laboratories''; and
(ii) by inserting ``and other emerging
substances related'' after ``analogues''; and
(D) in subparagraph (F), by inserting ``and
associated risk factors'' after ``overdoses''.
(b) Additional Grants.--Section 392A(a)(3) of the Public Health
Service Act (42 U.S.C. 280b-1(a)(3)) is amended--
(1) in the matter preceding subparagraph (A), by striking
``and Indian Tribes--'' and inserting ``and Indian Tribes for
the following purposes:'';
(2) by amending subparagraph (A) to read as follows:
``(A) To carry out innovative projects for grantees
to detect, identify, and rapidly respond to controlled
substance misuse, abuse, and overdoses, and associated
risk factors, including changes in patterns of such
controlled substance use. Such projects may include the
use of innovative, evidence-based strategies for
detecting such patterns, such as wastewater
surveillance, if proven to support actionable
prevention strategies, in a manner consistent with
applicable Federal and State privacy laws.''; and
(3) in subparagraph (B), by striking ``for any'' and
inserting ``For any''.
(c) Authorization of Appropriations.--Section 392A(e) of the Public
Health Service Act (42 U.S.C. 280b-1(e)) is amended by striking
``$496,000,000 for each of fiscal years 2019 through 2023'' and
inserting ``$505,579,000 for each of fiscal years 2026 through 2030''.
SEC. 104. SUPPORT FOR INDIVIDUALS AND FAMILIES IMPACTED BY FETAL
ALCOHOL SPECTRUM DISORDER.
(a) In General.--Part O of title III of the Public Health Service Act
(42 U.S.C. 280f et seq.) is amended to read as follows:
``PART O--FETAL ALCOHOL SPECTRUM DISORDER PREVENTION AND SERVICES
PROGRAM
``SEC. 399H. FETAL ALCOHOL SPECTRUM DISORDERS PREVENTION, INTERVENTION,
AND SERVICES DELIVERY PROGRAM.
``(a) In General.--The Secretary shall establish or continue
activities to support a comprehensive fetal alcohol spectrum disorders
(referred to in this section as `FASD') education, prevention,
identification, intervention, and services delivery program, which may
include--
``(1) an education and public awareness program to support,
conduct, and evaluate the effectiveness of--
``(A) educational programs targeting health
professions schools, social and other supportive
services, educators and counselors and other service
providers in all phases of childhood development, and
other relevant service providers, concerning the
prevention, identification, and provision of services
for infants, children, adolescents, and adults with
FASD;
``(B) strategies to educate school-age children,
including pregnant and high-risk youth, concerning
FASD;
``(C) public and community awareness programs
concerning FASD; and
``(D) strategies to coordinate information and
services across affected community agencies, including
agencies providing social services such as foster care,
adoption, and social work, agencies providing health
services, and agencies involved in education,
vocational training, and civil and criminal justice;
``(2) supporting and conducting research on FASD, as
appropriate, including to--
``(A) develop appropriate medical diagnostic methods
for identifying FASD; and
``(B) develop effective culturally and linguistically
appropriate evidence-based or evidence-informed
interventions and appropriate supports for preventing
prenatal alcohol exposure, which may co-occur with
exposure to other substances;
``(3) building State and Tribal capacity for the
identification, treatment, and support of individuals with FASD
and their families, which may include--
``(A) utilizing and adapting existing Federal, State,
or Tribal programs to include FASD identification and
FASD-informed support;
``(B) developing and expanding screening and
diagnostic capacity for FASD;
``(C) developing, implementing, and evaluating
targeted FASD-informed intervention programs for FASD;
``(D) providing training with respect to FASD for
professionals across relevant sectors; and
``(E) disseminating information about FASD and
support services to affected individuals and their
families; and
``(4) an applied research program concerning intervention and
prevention to support and conduct service demonstration
projects, clinical studies and other research models providing
advocacy, educational and vocational training, counseling,
medical and mental health, and other supportive services, as
well as models that integrate and coordinate such services,
that are aimed at the unique challenges facing individuals with
fetal alcohol spectrum disorder or fetal alcohol effect and
their families.
``(b) Grants and Technical Assistance.--
``(1) In general.--The Secretary may award grants,
cooperative agreements and contracts and provide technical
assistance to eligible entities to carry out subsection (a).
``(2) Eligible entities.--To be eligible to receive a grant,
or enter into a cooperative agreement or contract, under this
section, an entity shall--
``(A) be a State, Indian Tribe or Tribal
organization, local government, scientific or academic
institution, or nonprofit organization; and
``(B) prepare and submit to the Secretary an
application at such time, in such manner, and
containing such information as the Secretary may
require, including a description of the activities that
the entity intends to carry out using amounts received
under this section.
``(3) Additional application contents.--The Secretary may
require that an eligible entity include in the application
submitted under paragraph (2)(B)--
``(A) a designation of an individual to serve as a
FASD State or Tribal coordinator of activities such
eligible entity proposes to carry out through a grant,
cooperative agreement, or contract under this section;
and
``(B) a description of an advisory committee the
entity will establish to provide guidance for the
entity on developing and implementing a statewide or
Tribal strategic plan to prevent FASD and provide for
the identification, treatment, and support of
individuals with FASD and their families.
``(c) Definition of FASD-Informed.--For purposes of this section, the
term `FASD-informed', with respect to support or an intervention
program, means that such support or intervention program uses
culturally and linguistically informed evidence-based or practice-based
interventions and appropriate resources to support an improved quality
of life for an individual with FASD and the family of such individual.
``SEC. 399I. STRENGTHENING CAPACITY AND EDUCATION FOR FETAL ALCOHOL
SPECTRUM DISORDERS.
``(a) In General.--The Secretary shall award grants, contracts, or
cooperative agreements, as the Secretary determines appropriate, to
public or nonprofit private entities with demonstrated expertise in the
field of fetal alcohol spectrum disorders (referred to in this section
as `FASD'). Such awards shall be for the purposes of building local,
Tribal, State, and nationwide capacities to prevent the occurrence of
FASD by carrying out the programs described in subsection (b).
``(b) Programs.--An entity receiving an award under subsection (a)
may use such award for the following purposes:
``(1) Developing and supporting public education and outreach
activities to raise public awareness of the risks associated
with alcohol consumption during pregnancy.
``(2) Acting as a clearinghouse for evidence-based resources
on FASD prevention, identification, and culturally and
linguistically appropriate best practices to help inform
systems of care for individuals with FASD across their
lifespan.
``(3) Increasing awareness and understanding of efficacious,
evidence-based screening tools and culturally and
linguistically appropriate evidence-based intervention services
and best practices, which may include improving the capacity
for State, Tribal, and local affiliates.
``(4) Providing technical assistance to recipients of grants,
cooperative agreements, or contracts under section 399H, as
appropriate.
``(c) Application.--To be eligible for a grant, contract, or
cooperative agreement under this section, an entity shall submit to the
Secretary an application at such time, in such manner, and containing
such information as the Secretary may require.
``(d) Subcontracting.--A public or private nonprofit entity may carry
out the following activities required under this section through
contracts or cooperative agreements with other public and private
nonprofit entities with demonstrated expertise in FASD:
``(1) Resource development and dissemination.
``(2) Intervention services.
``(3) Training and technical assistance.
``SEC. 399J. AUTHORIZATION OF APPROPRIATIONS.
``There are authorized to be appropriated to carry out this part
$12,500,000 for each of fiscal years 2026 through 2030.''.
(b) Report.--Not later than 4 years after the date of enactment of
this Act, and every year thereafter, the Secretary of Health and Human
Services shall prepare and submit to the Committee on Health,
Education, Labor, and Pensions of the Senate and the Committee on
Energy and Commerce of the House of Representatives a report
containing--
(1) a review of the activities carried out pursuant to
sections 399H and 399I of the Public Health Service Act, as
amended, to advance public education and awareness of fetal
alcohol spectrum disorders (referred to in this section as
``FASD'');
(2) a description of--
(A) the activities carried out pursuant to such
sections 399H and 399I to identify, prevent, and treat
FASD; and
(B) methods used to evaluate the outcomes of such
activities; and
(3) an assessment of activities carried out pursuant to such
sections 399H and 399I to support individuals with FASD.
SEC. 105. PROMOTING STATE CHOICE IN PDMP SYSTEMS.
Section 399O(h) of the Public Health Service Act (42 U.S.C. 280g-
3(h)) is amended by adding at the end the following:
``(5) Promoting state choice.--Nothing in this section shall
be construed to authorize the Secretary to require States to
use a specific vendor or a specific interoperability connection
other than to align with nationally recognized, consensus-based
open standards, such as in accordance with sections 3001 and
3004.''.
SEC. 106. FIRST RESPONDER TRAINING PROGRAM.
Section 546 of the Public Health Service Act (42 U.S.C. 290ee-1) is
amended--
(1) in subsection (a), by striking ``tribes and tribal'' and
inserting ``Tribes and Tribal'';
(2) in subsections (a), (c), and (d)--
(A) by striking ``approved or cleared'' each place it
appears and inserting ``approved, cleared, or otherwise
legally marketed''; and
(B) by striking ``opioid'' each place it appears;
(3) in subsection (f)--
(A) by striking ``approved or cleared'' each place it
appears and inserting ``approved, cleared, or otherwise
legally marketed'';
(B) in paragraph (1), by striking ``opioid'';
(C) in paragraph (2)--
(i) by striking ``opioid and heroin'' and
inserting ``opioid, heroin, and other drug'';
and
(ii) by striking ``opioid overdose'' and
inserting ``overdose''; and
(D) in paragraph (3), by striking ``opioid and
heroin''; and
(4) in subsection (h), by striking ``$36,000,000 for each of
fiscal years 2019 thro
Purpose and Summary
The bill reauthorizes key public health programs that help
prevent drug overdoses, provide access to treatment for those
in need, and support opportunities for those recovering from
substance use disorder.
Background and Need for Legislation
The United States is currently facing an overdose crisis.
Substance addiction, abuse, and misuse remain a major public
health issue. Over 107,000 Americans lost their lives to a drug
overdose in 2023.\1\ In addition, 40 to 60 percent of
individuals treated for substance use disorders will relapse at
least once.\2\ Lastly, over 93 percent of people with a past-
year substance use disorder (SUD) did not receive specialty
treatment.\3\
---------------------------------------------------------------------------
\1\U.S. Drug Enforcement Administration (DEA), DEA Releases 2024
National Drug Threat Assessment, (May 2024), https://www.dea.gov/press-
releases/2024/05/09/dea-releases-2024-national-drug-threat-assessment.
\2\Maria Sugue, 2025 Addiction Statistics: Accurate Data on
Substance Abuse in the US, Addiction Group (Feb. 17, 2025), https://
www.addictiongroup.org/resources/addiction-statistics/.
\3\Id.
---------------------------------------------------------------------------
Congress took action to address the crisis in 2016 with the
passage of the Comprehensive Addiction and Recovery Act and the
21st Century Cares Act, which established new funding for
prevention, treatment, and recovery services for people
struggling with substance use disorder. The two laws attempted
to address a growing prescription opioid epidemic that, at the
time, was killing as many as 50,000 to 60,000 Americans per
year.\4\ However, as overdose deaths rose to nearly 70,000
deaths per year, Congress took further action in 2018 to tackle
the evolving crisis by passing the Substance Use-Disorder
Prevention That Promotes Opioid Recovery And Treatment For
Patients And Communities Act (or SUPPORT Act).\5\ The SUPPORT
Act was the largest investment in overdose prevention programs
by funding efforts to improve care, including efforts to reduce
barriers to all levels of the care continuum and allocate
resources to states and providers for the purposes of
preventing and treating substance use disorder.
---------------------------------------------------------------------------
\4\U.S. Centers for Disease Control and Prevention (CDC), Drug
Overdose Deaths in the United States, 1999-2016, National Center for
Health Statistics (Dec. 2017), https://www.cdc.gov/nchs/data/
databriefs/db356-h.pdf.
\5\CDC, Drug Overdose Deaths in the United States, 1999-2018,
National Center for Health Statistics (Jan. 2020), https://www.cdc.gov/
nchs/data/databriefs/db356-h.pdf.
---------------------------------------------------------------------------
Congress' work proved to be initially successful, evidenced
by annual overdose deaths decreasing for the first time since
2018.\6\ However, the current landscape has changed since 2018.
Fentanyl is now the primary driver of overdoses in the United
States, accounting for 70 percent of all overdose deaths.\7\
Further, the country is grappling with a mental health crisis,
fueled by the COVID-19 pandemic, which has driven millions of
new Americans to use and misuse drugs for the first time and
set back countless others on their road to recovery.\8\
---------------------------------------------------------------------------
\6\CDC, U.S. Overdose Deaths Decrease in 2023, First Time since
2018, National Center for Health Statistics (May 2024), https://
www.cdc.gov/nchs/pressroom/nchs_press_releases/2024/20240515.htm.
\7\DEA, DEA Releases 2024 National Drug Threat Assessment, (May
2024), https://www.dea.gov/press-releases/2024/05/09/dea-releases-2024-
national-drug-threat-assessment.
\8\CDC, Overdose Deaths Accelerating During COVID-19, CDC Archive
(Dec. 2020), https://
archive.cdc.gov/#/details?url=https://www.cdc.gov/media/releases/2020/
p1218-overdose-deaths-covid-19.html.
---------------------------------------------------------------------------
Key provisions from the SUPPORT Act expired in 2023. The
SUPPORT for Patients and Communities Reauthorization Act of
2025 would advance SUD treatment for patients and allocate
resources to strengthen the addiction treatment and workforce.
Committee Action
On June 9, 2023, the Subcommittee on Health held a field
hearing in Gettysburg, Pennsylvania, on issues related to
substance use disorder.\9\ The title of the hearing was
``Addressing the Opioid Crisis: Examining the SUPPORT Act Five
Years Later.'' The Subcommittee received testimony from:
---------------------------------------------------------------------------
\9\During the 118th Congress, this hearing was used to develop H.R.
4531.
---------------------------------------------------------------------------
Emily Keller, Special Secretary of Opioid
Response, Opioid Operational Command Center, Office of
Governor Wes Moore;
Mike Straley, Founder, Leah's Legacy
Foundation;
Mitchell Crawford, DO, Medical Director,
Specialized Treatment and Recovery, WellSpan Health,
Director, Addiction Services, WellSpan Health; and
William Ceravola, Reading Township Police
Department.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 4531.\10\ The title of the hearing was ``Responding to
America's Overdose Crisis: An Examination of Legislation to
Build Upon the SUPPORT Act.'' The Subcommittee received
testimony from:
---------------------------------------------------------------------------
\10\Provisions of H.R. 4531 were reintroduced in the 119th Congress
as H.R. 2483.
---------------------------------------------------------------------------
Matthew Strait, Deputy Assistant
Administrator, Office of Diversion Control for the Drug
Enforcement Administration;
Christopher Jones, Director of the National
Center for Injury Prevention and Control for the
Centers for Disease Control and Prevention;
Diana Espinosa, Principal Deputy
Administrator of the Health Resources and Services
Administration, Acting Deputy Assistant Secretary for
Mental Health and Substance Use;
Tom Coderre, Acting Deputy Assistant
Secretary for Mental Health and Substance Use; and
Jonathan Blum, Principal Deputy
Administrator and Chief Operating Officer for the
Centers for Medicare and Medicaid Services.
On July 13, 2023, the Subcommittee on Health met in open
markup session and forwarded H.R. 4531, without amendment, to
the full Committee by a voice vote.
On July 19, 2023, the full Committee on Energy and Commerce
met in open markup session and ordered H.R. 4531, as amended,
favorably reported to the House by a record vote of 48 yeas and
0 nays.
On April 29, 2025, the full Committee on Energy and
Commerce met in open markup session and ordered H.R. 2483, as
amended, favorably reported to the House by a record vote of 36
yeas and 13 nays.
Committee Votes
Clause 3(b) of rule XIII requires the Committee to list the
record votes on the motion to report legislation and amendments
thereto. The following reflects the record votes taken during
the Committee consideration:
[GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT]
Oversight Findings and Recommendations
Pursuant to clause 2(b)(1) of rule X and clause 3(c)(1) of
rule XIII, the Committee held hearings and made findings that
are reflected in this report.
New Budget Authority, Entitlement Authority,
and Tax Expenditures
Pursuant to clause 3(c)(2) of rule XIII, the Committee
finds that H.R. 2483 would result in no new or increased budget
authority, entitlement authority, or tax expenditures or
revenues.
Congressional Budget Office Estimate
Pursuant to clause 3(c)(3) of rule XIII, at the time this
report was filed, the cost estimate prepared by the Director of
the Congressional Budget Office pursuant to section 402 of the
Congressional Budget Act of 1974 was not available.
Federal Mandates Statement
The Committee adopts as its own the estimate of Federal
mandates prepared by the Director of the Congressional Budget
Office pursuant to section 423 of the Unfunded Mandates Reform
Act.
Statement of General Performance Goals and Objectives
Pursuant to clause 3(c)(4) of rule XIII, the general
performance goal or objective of this legislation is to
reauthorize certain programs that provide for opioid use
disorder prevention, recovery, and treatment, and for other
purposes.
Duplication of Federal Programs
Pursuant to clause 3(c)(5) of rule XIII, no provision of
H.R. 2483 is known to be duplicative of another Federal
program, including any program that was included in a report to
Congress pursuant to section 21 of Public Law 111-139 or the
most recent Catalog of Federal Domestic Assistance.
Related Committee and Subcommittee Hearings
Pursuant to clause 3(c)(6) of rule XIII, the following
related hearings were used to develop or consider H.R. 2483:
On June 9, 2023, the Subcommittee on Health
held a field hearing in Gettysburg, Pennsylvania, on
issues related to substance use disorder.\11\ The title
of the hearing was ``Addressing the Opioid Crisis:
Examining the SUPPORT Act Five Years Later.'' The
Subcommittee received testimony from:
---------------------------------------------------------------------------
\11\During the 118th Congress, this hearing was used to develop
H.R. 4531.
---------------------------------------------------------------------------
Emily Keller, Special Secretary
of Opioid Response, Opioid Operational Command
Center, Office of Governor Wes Moore;
Mike Straley, Founder, Leah's
Legacy Foundation;
Mitchell Crawford, DO, Medical
Director, Specialized Treatment and Recovery,
WellSpan Health, Director, Addiction Services,
WellSpan Health; and
William Ceravola, Reading
Township Police Department.
On June 21, 2023, the Subcommittee on Health
held a hearing on H.R. 4531. The title of the hearing
was ``Responding to America's Overdose Crisis: An
Examination of Legislation to Build Upon the SUPPORT
Act.'' Subcommittee received testimony from:
Matthew Strait, Deputy Assistant
Administrator, Office of Diversion Control for
the Drug Enforcement Administration;
Christopher Jones, Director of
the National Center for Injury Prevention and
Control for the Centers for Disease Control and
Prevention;
Diana Espinosa, Principal Deputy
Administrator of the Health Resources and
Services Administration, Acting Deputy
Assistant Secretary for Mental Health and
Substance Use;
Tom Coderre, Acting Deputy
Assistant Secretary for Mental Health and
Substance Use; and
Jonathan Blum, Principal Deputy
Administrator and Chief Operating Officer for
the Centers for Medicare and Medicaid Services.
Committee Cost Estimate
Pursuant to clause 3(d)(1) of rule XIII, the Committee
adopts as its own the cost estimate prepared by the Director of
the Congressional Budget Office pursuant to section 402 of the
Congressional Budget Act of 1974. At the time this report was
filed, the estimate was not available.
Earmark, Limited Tax Benefits, and Limited Tariff Benefits
Pursuant to clause 9(e), 9(f), and 9(g) of rule XXI, the
Committee finds that H.R. 2483 contains no earmarks, limited
tax benefits, or limited tariff benefits.
Advisory Committee Statement
No advisory committees within the meaning of section 5(b)
of the Federal Advisory Committee Act were created by this
legislation.
Applicability to Legislative Branch
The Committee finds that the legislation does not relate to
the terms and conditions of employment or access to public
services or accommodations within the meaning of section
102(b)(3) of the Congressional Accountability Act.
Section-by-Section Analysis of the Legislation
Section 1. Short title; table of contents
Section 1 provides that the Act may be cited as the
``SUPPORT for Patients and Communities Reauthorization Act of
2025.'' In addition, this section also provides a table of
contents for the Act.
TITLE I--PREVENTION
Section 101. Prenatal and postnatal health
This section reauthorizes section 317L of the Public Health
Service Act for fiscal year (FY) 2026 through FY 2030 to
continue activities to address neonatal abstinence syndrome and
prenatal substance use and misuse, as well as to continue
efforts to understand the outcomes of treating opioid use
disorder during pregnancy.
Section 102. Monitoring and education regarding infections associated
with illicit drug use and other risk factors
This section reauthorizes section 317N of the Public Health
Service Act for FY 2026 through FY 2030 to continue efforts to
prevent and respond to infections commonly associated with
illicit drug use.
Section 103. Preventing overdoses of controlled substances
This section reauthorizes section 392A of the Public Health
Service Act for FY 2026 through FY 2030 to continue support for
State efforts to enhance overdose data collection and improve
prescription drug monitoring programs (PDMP).
Section 104. Support for individuals and families impacted by fetal
alcohol spectrum disorder
This section reauthorizes federal fetal alcohol spectrum
disorder programs under the Department of Health and Human
Services (HHS) that support prevention, education,
intervention, and research for FY 2026 through FY 2030.
Section 105. Promoting state choice in PDMP systems
This section clarifies that HHS cannot require states to
use a specific vendor or interoperability connection in PDMP
systems.
Section 106. First responder training
This section reauthorizes section 546 of the Public Health
Service Act for FY 2026 through FY 2030. This program helps
support first responders and members of other key community
sectors to administer a drug or device approved or cleared
under the Federal Food, Drug, and Cosmetic Act for emergency
treatment of known or suspected opioid overdose.
Section 107. Donald J. Cohen National Child Traumatic Stress Initiative
This section reauthorizes section 582 of the Public Health
Service Act for FY 2026 through FY 2030. This program supports
training initiatives focused on mental, behavioral, and
biological aspects of psychological trauma response, prevention
of long-term consequences of child trauma, and early
intervention services to address long-term impacts of child
trauma.
Section 108. Protecting suicide prevention lifeline from cybersecurity
incidents
This section requires internal coordination within HHS and
improved reporting mechanisms to protect the 9-8-8 Suicide &
Crisis Lifeline from cybersecurity incidents. This also
requires a study and report to Congress of any cybersecurity
vulnerabilities associated with the Lifeline.
Section 109. Monitoring and reporting of child, youth, and adult trauma
This section reauthorizes section 7131(e) of the SUPPORT
for Patients and Communities Act for FY 2026 through FY 2030 to
continue efforts to collect and report information on adverse
childhood experiences.
Section 110. Bruce's law
This section allows HHS to develop a public education and
awareness campaign focused on drug overdose prevention,
detection of early warning signs of addiction among youth, and
dangers of drugs that could be contaminated with fentanyl. In
addition, this section allows the Secretary of HHS to begin a
Federal Interagency Working Group on Fentanyl Contamination of
Illegal Drugs.
Section 111. Guidance on at-home drug disposal systems
This section directs the Food and Drug Administration
(FDA), in consultation with the Drug Enforcement Administration
(DEA), to issue guidance to facilitate the use of at-home safe
disposal systems. Such guidance shall include recommended
standards to meet relevant requirements, recommended
instructions for use both at-home and for licensed health
providers disseminating information, as well as best practices
and educational tools to support effective use of such systems.
Section 112. Assessment of opioid drugs and actions
This section requires the Secretary of HHS to publish a
report outlining a plan for assessing approved opioid analgesic
drugs that addresses the public health effects of these drugs
as part of a benefit-risk assessment, as well as an update on
FDA's activities related to developing nonaddictive medical
products. This section requires that HHS provide an opportunity
for public input regarding FDA's regulation of opioid analgesic
drugs.
Section 113. Grant program for State and Tribal response to opioid use
disorders
This section clarifies that the Substance Abuse and Mental
Health Services Administration's (SAMHSA's) State and Tribal
opioid response grants may be used for fentanyl or xylazine
test strips in States where they are legal.
TITLE II--TREATMENT
Section 201. Residential treatment program for pregnant and postpartum
women
This section reauthorizes section 508 of the Public Health
Service Act for FY 2026 through FY 2030. This program helps
support residential treatment recovery services for pregnant
and postpartum women with substance use disorder.
Section 202. Improving access to addiction medicine providers
This section adds addiction medicine specialists to the
eligible entities under the Fellowship Program.
Section 203. Mental and behavioral health education and training grants
This section reauthorizes section 756 of the Public Health
Service Act for FY 2026 through FY 2030. This program helps
recruit and educate students to pursue careers in the fields of
behavioral and mental health, including substance use disorder
treatment.
Section 204. Loan repayment program for substance use disorder
treatment workforce
This section reauthorizes section 781 of the Public Health
Service Act for FY 2026 through FY 2030. This program, known as
the ``STAR Loan Repayment Program,'' helps recruit and retain
substance use disorder professionals.
Section 205. Development and dissemination of model training programs
for substance use disorder patient records
This section strikes the authorization of appropriations
for Section 7053 of the SUPPORT for Patients and Communities
Act.
Section 206. Task force on best practices for trauma-informed
identification, referral, and support
This section extends the authority for section 7132 of the
SUPPORT Act, known as the Interagency Task Force on Trauma-
Informed Care, to identify, evaluate, and make recommendations
on best practices with respect to children and youth who may
experience trauma, through 2030.
Section 207. Grants to enhance access to substance use disorder
treatment
This section strikes the authorization of appropriations
for Section 3203 of the SUPPORT for Patients and Communities
Act.
Section 208. State guidance related to individuals with serious mental
illness and children with serious emotional disturbance
This section requires SAMHSA to review State uses of
funding for activities to identify and address early serious
mental illness and children with a serious emotional
disturbance under the Community Mental Health Services Block
Grant program. This also requires the Secretary to publish a
report to Congress and update related guidance to States based
on its findings to improve the quality of care provided through
Block Grant funds.
Section 209. Reviewing the scheduling of approved products containing a
combination of buprenorphine and naloxone
This section requires HHS and DEA to review the scheduling
of buprenorphine-naloxone combination products under the
Controlled Substances Act.
TITLE III--RECOVERY
Section 301. Building communities of recovery
This section reauthorizes section 547 of the Public Health
Service Act for FY 2026 through FY 2030. This program helps
support recovery community organizations to develop, expand,
and enhance recovery services.
Section 302. Peer support technical assistance center
This section reauthorizes the National Peer-Run Training
and Technical Assistance Center for Addiction Recovery Support,
which supports recovery community organizations and peer
support networks that provide substance use disorder peer
support services. Additionally, this allows for a regional
approach to providing this technical assistance.
Section 303. Comprehensive opioid recovery centers
This section reauthorizes section 552 of the Public Health
Service Act for FY 2026 through FY 2030. This program supports
the operation of comprehensive opioid recovery centers that
provide a full spectrum of treatment and recovery support
services for individuals with substance use disorder.
Section 304. Youth prevention and recovery
This section reauthorizes section 7102 of the SUPPORT Act
for FY 2026 through FY 2030. This program provides support for
prevention, treatment, and recovery for children, adolescents,
and young adults suffering from substance use disorder.
Section 305. CAREER Act
This section reauthorizes Section 7183 and 8071 of the
SUPPORT Act for FY 2026 through FY 2030. This program provides
grants for substance use disorder treatment programs that help
individuals in recovery re-enter the workforce, including
support for recovery housing.
Section 306. Addressing economic and workforce impacts of the opioid
crisis
This section reauthorizes section 8041 of the SUPPORT Act
for FY 2026 through FY 2030 to continue resources to address
various economic impacts associated with a high rate of
substance use disorder in a given area.
TITLE IV--MISCELLANEOUS MATTERS
Section 401. Delivery of a controlled substance by a pharmacy to a
prescribing practitioner
This section clarifies that pharmacies may deliver a
Schedule III, IV, or V controlled substance to an administering
practitioner, with post administration monitoring requirements,
in lieu of delivering such substances to the ultimate user.
Section 402. Required training for prescribers of controlled substances
This section makes technical changes to training
requirements for prescribers of opioids by including additional
professional societies and accrediting bodies.
Changes in Existing Law Made by the Bill, as Reported
In compliance with clause 3(e) of rule XIII of the Rules of
the House of Representatives, changes in existing law made by
the bill, as reported, are shown as follows (existing law
proposed to be omitted is enclosed in black brackets, new
matter is printed in italics, and existing law in which no
change is proposed is shown in roman):
PUBLIC HEALTH SERVICE ACT
* * * * * * *
TITLE III--GENERAL POWERS AND DUTIES OF PUBLIC
HEALTH SERVICE
* * * * * * *
Part B--Federal-State Cooperation
* * * * * * *
prenatal and postnatal health
Sec. 317L. (a) In General.--The Secretary, acting through the
Director of the Centers for Disease Control and Prevention,
shall carry out programs--
(1) to collect, analyze, and make available data on
prenatal smoking and alcohol and other substance abuse
and misuse, including--
(A) data on--
(i) the incidence, prevalence, and
implications of such activities; and
(ii) the incidence and prevalence of
implications and outcomes, including
neonatal abstinence syndrome and other
maternal and child health outcomes
associated with such activities; and
(B) additional information or data, as
appropriate, on family health history,
medication exposures during pregnancy,
demographic information, such as race,
ethnicity, geographic location, and family
history, and other relevant information, to
inform such analysis;
(2) to conduct applied epidemiological research on
the prevention and long-term outcomes associated with
prenatal and postnatal smoking, alcohol and other
substance abuse and misuse;
(3) to support, conduct, and evaluate the
effectiveness of educational, treatment, and cessation
programs;
(4) to provide information and education to the
public on the prevention and implications of prenatal
and postnatal smoking, alcohol and other substance
abuse and misuse; and
(5) to issue public reports on the analysis of data
described in paragraph (1), including analysis of--
(A) long-term outcomes of children affected
by neonatal abstinence syndrome;
(B) health outcomes associated with prenatal
smoking, alcohol, and substance abuse and
misuse; and
(C) relevant studies, evaluations, or
information the Secretary determines to be
appropriate.
(b) Grants.--In carrying out subsection (a), the Secretary
may award grants to and enter into contracts with States, local
governments, tribal entities, scientific and academic
institutions, federally qualified health centers, and other
public and nonprofit entities, and may provide technical and
consultative assistance to such entities.
(c) Coordinating Activities.--To carry out this section, the
Secretary may--
(1) provide technical and consultative assistance to
entities receiving grants under subsection (b);
(2) ensure a pathway for data sharing between States,
tribal entities, and the Centers for Disease Control
and Prevention;
(3) ensure data collection under this section is
consistent with applicable State, Federal, and Tribal
privacy laws; and
(4) coordinate with the National Coordinator for
Health Information Technology, as appropriate, to
assist States and Tribes in implementing systems that
use standards recognized by such National Coordinator,
as such recognized standards are available, in order to
facilitate interoperability between such systems and
health information technology systems, including
certified h
Minority Views
H.R. 2483, the SUPPORT for Patients and Communities
Reauthorization Act of 2025, reauthorizes public health
programs that help address the ongoing opioid epidemic. This
historically bipartisan bill should have continued to earn
bipartisan support, but Congressional Republicans have refused
to conduct proper oversight of the Trump Administration's
dismantling of the Substance Abuse and Mental Health Services
Administration (SAMHSA), the agency responsible for the United
States' response to ongoing mental health and substance use
disorder crises and for carrying out many of the programs
reauthorized by H.R. 2483.
On February 14, 2025, the Trump Administration fired
approximately 100 probationary employees at SAMHSA.\1\ This was
more than 10 percent of the agency's workforce.\2\ On April 1,
2025, there was another round of mass firing at the agency as
part of a department-wide Reduction in Force (RIF), including
senior officials such as the Director of the Center for Mental
Health Services and the Director of the Center for Substance
Use Treatment.\3\ The Administration has refused to answer
written questions regarding exactly how many people were fired,
despite repeated requests from the Ranking Member and Minority
Committee staff. However, reports indicate that up 50 percent
of the agency's staff have been fired.\4\
---------------------------------------------------------------------------
\1\`Deliberate Trauma': SAMHSA Employees Detail a Federal Agency in
Shambles, STAT (Mar. 12, 2025).
\2\Department of Health and Human Services, Fiscal Year 2025
Substance Use and Mental Health Services Administration Justification
of Estimates for Appropriations Committees. (https://www.samhsa.gov/
sites/default/files/samhsa-fy-2025-cj.pdf) (accessed Apr. 30, 2025).
\3\SAMHSA Firings Continue, Devastating U.S. Mental Health Agency,
MindSite News (Apr. 1, 2025).
\4\As SAMHSA Cuts Loom, Behavioral Health Orgs Fight to Protect
Funding, Filter (Apr. 17, 2025).
---------------------------------------------------------------------------
In March, the Trump Administration also revealed plans to
eliminate SAMHSA altogether and combine mental health and
substance use programs with unrelated programs such as
occupational health and safety and toxic substances in a new
``Administration for a Healthy America.''\5\ This action will
deprioritize mental health and substance use efforts within the
federal government, and it has been opposed by dozens of
leading mental health and substance use groups.\6\
---------------------------------------------------------------------------
\5\Department of Health and Human Services, HHS Announces
Transformation to Make America Healthy Again (Mar. 27, 2025) (press
release).
\6\Legal Action Center, Joint Statement Opposing SAMHSA Cuts and
Any Harmful HHS Restructuring (Apr. 15, 2025) (press release).
---------------------------------------------------------------------------
At the same time, the Trump Administration illegally
rescinded over $1 billion from state and local behavioral
health programs under Mental Health and Substance Use Block
Grant funding.\7\ These funds were appropriated by the American
Rescue Plan Act during the COVID-19 pandemic, but the funding
was never limited to be used only for COVID-19 activities or
during a public health emergency. The funding was already
obligated to states and rescinding it has only undermined
States' ability to address the overdose crisis.
---------------------------------------------------------------------------
\7\Trump Administration Abruptly Cuts Billions From State Health
Services, The New York Times (Mar. 26, 2025).
---------------------------------------------------------------------------
On April 16, 2025, an internal budget document revealed the
Trump Administration's plans for drastic cuts across the
Department of Health and Human Services (HHS).\8\ The document
listed out specific programs that are poised to be eliminated,
including 40 different mental health and substance use
programs. Among these programs were eight programs reauthorized
by H.R. 2483, including programs that train first responders
for overdose response, provide residential treatment for
pregnant and postpartum women, a task force on best practices
for trauma-informed care, support the full spectrum of recovery
services, target youth substance use disorder prevention, and
help individuals in recovery reenter the workforce.\9\
---------------------------------------------------------------------------
\8\Internal Budget Document Reveals Extent of Trump's Proposed
Health Cuts, The Washington Post (Apr. 16, 2025).
\9\The Leaked OMB Passback Document: What It Is and Isn't,
McDermott+ (Apr. 24, 2025).
---------------------------------------------------------------------------
Congressional Republicans have stood silently by while the
Trump Administration decimates our mental health and substance
use prevention, treatment, and recovery landscape. It is
Congress' job to ensure that agencies can continue their
critical work and that authorized programs are not arbitrarily
and illegally slashed. Without proper Congressional oversight,
there is little evidence to inspire confidence that H.R. 2438
will be faithfully implemented, or that we can make meaningful
progress to combat the opioid crisis or improve the mental
health and well being of all Americans.
Frank Pallone, Jr.,
Ranking Member.
[GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT]
[all]